The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir). The warning describes potentially life-threatening cardiovascular side effects the drug is used with Norvir (ritonavir). Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230442.htm.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.